Skip to main content

Call for papers - Drugs and gut microbiome interactions

Guest Editors:
Imran Khan: Department of Biotechnology, Faculty of Chemical and Life Sciences, Abdul Wali Khan University Mardan, KPK, Pakistan
Mohammad Taheri: Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Submission Status: Open   |   Submission Deadline: 2 January 2024


BMC Pharmacology and Toxicology is calling for submissions to our Collection on the drugs and gut microbiome interactions.
 
In the past decade, our understanding of the human gut microbiome's role in mediating human health has emerged rapidly. From autoimmune disorders to psychiatric disorders, recent studies have shown the associations between the presence and abundance of various gut bacteria with health conditions. The gut microbiome's role as a crucial mediator of drug metabolism is increasingly recognised, with the interactions between drugs and the gut microbiome being a complex bidirectional system.

Meet the Guest Editors

Back to top

Imran Khan: Department of Biotechnology, Faculty of Chemical and Life Sciences, Abdul Wali Khan University Mardan, KPK, Pakistan

Dr Imran Khan is an Assistant Professor of Biotechnology at Abdul Wali Khan University Mardan, where he focuses on researching Host-Microbe Interaction, Gut Microbiome, and Microbial Bioinformatics. Dr Khan was awarded Fellowship under the Global Talent Program of the Macau Government for two years. He also worked as a Senior Lecturer at the University of Malaysia Sabah, and as research associate in the industrial biotechnology division of National Institute for Biotechnology and Genetic Engineering, Faisalabad, Pakistan.

Mohammad Taheri: Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Dr Mohammad Taheri is an Assistant Professor at Department of Medical Microbiology at Hamadan University of Medical Sciences, Iran.  His research interests include Recombinant Proteins in Microbiology, PFGE, Phylogenetic Study, Real Time PCR, Nanobiotechnology , Bioprocess and Fermentation, Enzyme technology and Bactofection. 

 


About the collection

BMC Pharmacology and Toxicology is calling for submissions to our Collection on the drugs and gut microbiome interactions. 

In the past decade, our understanding of the human gut microbiome's role in mediating human health has emerged rapidly. From autoimmune disorders to psychiatric disorders, recent studies have shown the associations between the presence and abundance of various gut bacteria with health conditions. The gut microbiome's role as a crucial mediator of drug metabolism is increasingly recognised, with the interactions between drugs and the gut microbiome being a complex bidirectional system. Studies have shown that gut microbiota can contribute and influence drug safety, pharmacodynamics, and bioavailability, bearing potential implications on drug discovery and formulation.

BMC Pharmacology and Toxicology is launching this collection to provide a platform for research on the broad areas relating to drugs and gut microbiota interactions. We welcome studies from diverse fields of research, including microbiology, pharmacology and toxicology, clinical medicine, and bioinformatics. We would like to encourage studies looking into, but not limited to, antibiotic and gut microbiota interplay, the influence of gut microbiota on drug pharmacodynamics and pharmacokinetics, impact of dietary interventions on gut microbiota and its effect on drug interactions, and the use of big data for studying drugs and gut microbiota interactions.

Image credit: troyanphoto / stock.adobe.com

Submission Guidelines

Back to top

This Collection welcomes submission of Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Drugs and gut microbiome interactions" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.